網膜治療薬のグローバル市場2023-2027:病院薬局、小売薬局、オンライン薬局

【英語タイトル】Global Retinal Drugs Market 2023-2027

Technavioが出版した調査資料(IRTNTR70326-23)・商品コード:IRTNTR70326-23
・発行会社(調査会社):Technavio
・発行日:2023年1月23日
・ページ数:約120
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:北米、ヨーロッパ、アジア、その他地域
・産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥370,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥592,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

Technavio社の本調査レポートでは、世界の網膜治療薬市場規模が2023年から2027年の間に7,275.79百万ドルに到達すると見込んでおり、予測期間中の年平均成長率は6.27%になると予想しています。本レポートでは、網膜治療薬の世界市場について広く調査を行い、エグゼクティブサマリー、市場状況、市場規模予測、過去の市場規模、ファイブフォース分析、流通チャネル別(病院薬局、小売薬局、オンライン薬局)分析、適応症別(黄斑変性症、糖尿病性眼疾患、その他)分析、顧客状況、地域別(北米、ヨーロッパ、アジア、アメリカ、中国、ドイツ、スペイン、カナダ、その他地域)分析、企業分析など、以下の構成でまとめています。本レポートには、Bayer AG、AbbVie Inc.、Alcon Inc.、Alimera Sciences Inc.、Bausch Health Co Inc.、Bristol Myers Squibb Co.、F. Hoffmann La Roche Ltd.、Kubota Corp.、MeiraGTx Holdings Plc、Novartis AG、Ocular Therapeutix Inc.、Oxurion NV、Pfizer Inc.、Regeneron Pharmaceuticals Inc.、REGENXBIO Inc、Sanofi SA、Santen Pharmaceutical Co. Ltd.、Teva Pharmaceutical Industries Ltd.、Visufarma、Johnson and Johnson Services Inc.Xなどの企業情報が含まれています。
・エグゼクティブサマリー
・市場状況
・市場規模予測
・過去の市場規模
・ファイブフォース分析
・世界の網膜治療薬市場規模:流通チャネル別
- 病院薬局チャネルの市場規模
- 小売薬局チャネルの市場規模
- オンライン薬局チャネルの市場規模
・世界の網膜治療薬市場規模:適応症別
- 黄斑変性症における市場規模
- 糖尿病性眼疾患における市場規模
- その他における市場規模
・顧客状況
・世界の網膜治療薬市場規模:地域別
- 北米の網膜治療薬市場規模
- ヨーロッパの網膜治療薬市場規模
- アジアの網膜治療薬市場規模
- アメリカの網膜治療薬市場規模
- 中国の網膜治療薬市場規模
- ドイツの網膜治療薬市場規模
- スペインの網膜治療薬市場規模
- カナダの網膜治療薬市場規模
- その他地域の網膜治療薬市場規模
・成長要因・課題・動向
・企業状況
・企業分析

Technavio社は、利益、価格、競争、プロモーションなどの主要なパラメーターを分析することにより、また複数のソースからのデータを調査、統合、および合計することにより、網膜治療薬市場の詳細な全体像を提示します。主要産業のインフルエンサーを特定することにより、さまざまな市場の側面を提示します。提示されたデータは包括的​​で信頼性が高く、一次および二次の広範な調査の結果です。 Technavio社の市場調査レポートは、正確な網膜治療薬市場の成長を予測するための定性的および定量的調査を使用し、完全な競争状況と詳細なベンダー選択方法と分析を提供します。

網膜治療薬の世界市場 2023-2027

Technavio社は、網膜治療薬市場をモニターしており、2022年から2027年にかけて7,275.79百万ドルの成長が予測され、予測期間中のCAGRは6.27%で加速すると予測しています。当レポートでは、網膜治療薬市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題に加え、約25のベンダーを網羅したベンダー分析も提供しています。

当レポートでは、現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、網膜疾患の有病率の上昇、高度な診断ツールの出現、患者支援プログラムが牽引しています。

Technavio社の網膜治療薬市場は以下のように分類されています:

・流通チャネル別:
- 病院薬局
- 小売薬局
- オンライン薬局

・疾患別:
- 黄斑変性症
- 糖尿病性眼疾患
- その他

・地域別:
- 北米
- ヨーロッパ
- アジア
- その他の地域(ROW)

本調査では、革新的な治療法の開発が、今後数年間の網膜治療薬市場の成長を促進する主な理由の1つであると特定しています。また、徐放性眼科用製剤の需要の増加や診断技術の進歩も、市場の大きな需要につながるでしょう。

Technavio社は、複数の情報源からのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。

当レポートでは、網膜治療薬市場について以下の分野をカバーしています:
- 網膜治療薬市場のサイジング
- 網膜治療薬市場の予測
- 網膜治療薬市場の産業分析

Technavio社の確実なベンダー分析は、クライアントが市場でのポジションを向上できるように設計されており、これに沿って本レポートには、Bayer AG, AbbVie Inc., Alcon Inc., Alimera Sciences Inc., Bausch Health Co Inc., Bristol Myers Squibb Co., F. Hoffmann La Roche Ltd., Kubota Corp., MeiraGTx Holdings Plc, Novartis AG, Ocular Therapeutix Inc., Oxurion NV, Pfizer Inc., Regeneron Pharmaceuticals Inc., REGENXBIO Inc, Sanofi SA, Santen Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., Visufarma, and Johnson and Johnson Services Incなどの企業情報が含まれています。また、網膜治療薬の市場分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を練り、来るべき成長機会をすべて活用するのに役立つものです。

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートでは、主要ベンダーの分析に加え、包括的な市場およびベンダーの状況を掲載しています。

Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細な姿を提示します。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示します。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

❖ レポートの目次 ❖

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market by Geography
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Distribution Channel
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Indication
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global retinal drugs market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on Global retinal drugs market 2017 – 2021 ($ million)
o 4.2 Ditribution channel Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Ditribution channel Segment 2017 – 2021 ($ million)
o 4.3 Indication Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – Indication Segment 2017 – 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
• 6 Market Segmentation by Distribution Channel
o 6.1 Market segments
o Exhibit 30: Chart on Distribution Channel – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Distribution Channel – Market share 2022-2027 (%)
o 6.2 Comparison by Distribution Channel
o Exhibit 32: Chart on Comparison by Distribution Channel
o Exhibit 33: Data Table on Comparison by Distribution Channel
o 6.3 Hospital pharmacy – Market size and forecast 2022-2027
o Exhibit 34: Chart on Hospital pharmacy – Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Hospital pharmacy – Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Hospital pharmacy – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Hospital pharmacy – Year-over-year growth 2022-2027 (%)
o 6.4 Retail pharmacy – Market size and forecast 2022-2027
o Exhibit 38: Chart on Retail pharmacy – Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Retail pharmacy – Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Retail pharmacy – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Retail pharmacy – Year-over-year growth 2022-2027 (%)
o 6.5 Online pharmacy – Market size and forecast 2022-2027
o Exhibit 42: Chart on Online pharmacy – Market size and forecast 2022-2027 ($ million)
o Exhibit 43: Data Table on Online pharmacy – Market size and forecast 2022-2027 ($ million)
o Exhibit 44: Chart on Online pharmacy – Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Online pharmacy – Year-over-year growth 2022-2027 (%)
o 6.6 Market opportunity by Distribution Channel
o Exhibit 46: Market opportunity by Distribution Channel ($ million)
• 7 Market Segmentation by Indication
o 7.1 Market segments
o Exhibit 47: Chart on Indication – Market share 2022-2027 (%)
o Exhibit 48: Data Table on Indication – Market share 2022-2027 (%)
o 7.2 Comparison by Indication
o Exhibit 49: Chart on Comparison by Indication
o Exhibit 50: Data Table on Comparison by Indication
o 7.3 Macular degeneration – Market size and forecast 2022-2027
o Exhibit 51: Chart on Macular degeneration – Market size and forecast 2022-2027 ($ million)
o Exhibit 52: Data Table on Macular degeneration – Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Chart on Macular degeneration – Year-over-year growth 2022-2027 (%)
o Exhibit 54: Data Table on Macular degeneration – Year-over-year growth 2022-2027 (%)
o 7.4 Diabetic eye disease – Market size and forecast 2022-2027
o Exhibit 55: Chart on Diabetic eye disease – Market size and forecast 2022-2027 ($ million)
o Exhibit 56: Data Table on Diabetic eye disease – Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Chart on Diabetic eye disease – Year-over-year growth 2022-2027 (%)
o Exhibit 58: Data Table on Diabetic eye disease – Year-over-year growth 2022-2027 (%)
o 7.5 Others – Market size and forecast 2022-2027
o Exhibit 59: Chart on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 60: Data Table on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 61: Chart on Others – Year-over-year growth 2022-2027 (%)
o Exhibit 62: Data Table on Others – Year-over-year growth 2022-2027 (%)
o 7.6 Market opportunity by Indication
o Exhibit 63: Market opportunity by Indication ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 65: Chart on Market share by geography 2022-2027 (%)
o Exhibit 66: Data Table on Market share by geography 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 67: Chart on Geographic comparison
o Exhibit 68: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 69: Chart on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 70: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 71: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 72: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 73: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 74: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 75: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 76: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 77: Chart on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 78: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 79: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 80: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 81: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 82: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 83: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 84: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 85: Chart on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 86: Data Table on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 87: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 88: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 China – Market size and forecast 2022-2027
o Exhibit 89: Chart on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 90: Data Table on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 91: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 92: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.9 Germany – Market size and forecast 2022-2027
o Exhibit 93: Chart on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 94: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 95: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 96: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.10 Spain – Market size and forecast 2022-2027
o Exhibit 97: Chart on Spain – Market size and forecast 2022-2027 ($ million)
o Exhibit 98: Data Table on Spain – Market size and forecast 2022-2027 ($ million)
o Exhibit 99: Chart on Spain – Year-over-year growth 2022-2027 (%)
o Exhibit 100: Data Table on Spain – Year-over-year growth 2022-2027 (%)
o 9.11 Canada – Market size and forecast 2022-2027
o Exhibit 101: Chart on Canada – Market size and forecast 2022-2027 ($ million)
o Exhibit 102: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
o Exhibit 103: Chart on Canada – Year-over-year growth 2022-2027 (%)
o Exhibit 104: Data Table on Canada – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity by geography
o Exhibit 105: Market opportunity by geography ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 106: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 107: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 108: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 109: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 110: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 111: Matrix on vendor position and classification
o 12.3 AbbVie Inc.
o Exhibit 112: AbbVie Inc. – Overview
o Exhibit 113: AbbVie Inc. – Product / Service
o Exhibit 114: AbbVie Inc. – Key news
o Exhibit 115: AbbVie Inc. – Key offerings
o 12.4 Alcon Inc.
o Exhibit 116: Alcon Inc. – Overview
o Exhibit 117: Alcon Inc. – Business segments
o Exhibit 118: Alcon Inc. – Key offerings
o Exhibit 119: Alcon Inc. – Segment focus
o 12.5 Alimera Sciences Inc.
o Exhibit 120: Alimera Sciences Inc. – Overview
o Exhibit 121: Alimera Sciences Inc. – Product / Service
o Exhibit 122: Alimera Sciences Inc. – Key offerings
o 12.6 Bausch Health Co Inc.
o Exhibit 123: Bausch Health Co Inc. – Overview
o Exhibit 124: Bausch Health Co Inc. – Business segments
o Exhibit 125: Bausch Health Co Inc. – Key news
o Exhibit 126: Bausch Health Co Inc. – Key offerings
o Exhibit 127: Bausch Health Co Inc. – Segment focus
o 12.7 Bayer AG
o Exhibit 128: Bayer AG – Overview
o Exhibit 129: Bayer AG – Business segments
o Exhibit 130: Bayer AG – Key news
o Exhibit 131: Bayer AG – Key offerings
o Exhibit 132: Bayer AG – Segment focus
o 12.8 Bristol Myers Squibb Co.
o Exhibit 133: Bristol Myers Squibb Co. – Overview
o Exhibit 134: Bristol Myers Squibb Co. – Product / Service
o Exhibit 135: Bristol Myers Squibb Co. – Key news
o Exhibit 136: Bristol Myers Squibb Co. – Key offerings
o 12.9 F. Hoffmann La Roche Ltd.
o Exhibit 137: F. Hoffmann La Roche Ltd. – Overview
o Exhibit 138: F. Hoffmann La Roche Ltd. – Business segments
o Exhibit 139: F. Hoffmann La Roche Ltd. – Key news
o Exhibit 140: F. Hoffmann La Roche Ltd. – Key offerings
o Exhibit 141: F. Hoffmann La Roche Ltd. – Segment focus
o 12.10 Johnson and Johnson Services Inc.
o Exhibit 142: Johnson and Johnson Services Inc. – Overview
o Exhibit 143: Johnson and Johnson Services Inc. – Business segments
o Exhibit 144: Johnson and Johnson Services Inc. – Key news
o Exhibit 145: Johnson and Johnson Services Inc. – Key offerings
o Exhibit 146: Johnson and Johnson Services Inc. – Segment focus
o 12.11 MeiraGTx Holdings Plc
o Exhibit 147: MeiraGTx Holdings Plc – Overview
o Exhibit 148: MeiraGTx Holdings Plc – Product / Service
o Exhibit 149: MeiraGTx Holdings Plc – Key offerings
o 12.12 Novartis AG
o Exhibit 150: Novartis AG – Overview
o Exhibit 151: Novartis AG – Business segments
o Exhibit 152: Novartis AG – Key offerings
o Exhibit 153: Novartis AG – Segment focus
o 12.13 Ocular Therapeutix Inc.
o Exhibit 154: Ocular Therapeutix Inc. – Overview
o Exhibit 155: Ocular Therapeutix Inc. – Product / Service
o Exhibit 156: Ocular Therapeutix Inc. – Key offerings
o 12.14 Oxurion NV
o Exhibit 157: Oxurion NV – Overview
o Exhibit 158: Oxurion NV – Product / Service
o Exhibit 159: Oxurion NV – Key offerings
o 12.15 Pfizer Inc.
o Exhibit 160: Pfizer Inc. – Overview
o Exhibit 161: Pfizer Inc. – Product / Service
o Exhibit 162: Pfizer Inc. – Key news
o Exhibit 163: Pfizer Inc. – Key offerings
o 12.16 Regeneron Pharmaceuticals Inc.
o Exhibit 164: Regeneron Pharmaceuticals Inc. – Overview
o Exhibit 165: Regeneron Pharmaceuticals Inc. – Product / Service
o Exhibit 166: Regeneron Pharmaceuticals Inc. – Key offerings
o 12.17 Sanofi SA
o Exhibit 167: Sanofi SA – Overview
o Exhibit 168: Sanofi SA – Business segments
o Exhibit 169: Sanofi SA – Key news
o Exhibit 170: Sanofi SA – Key offerings
o Exhibit 171: Sanofi SA – Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 172: Inclusions checklist
o Exhibit 173: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 174: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 175: Research methodology
o Exhibit 176: Validation techniques employed for market sizing
o Exhibit 177: Information sources
o 13.5 List of abbreviations
o Exhibit 178: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market by Geography
Exhibits5: Executive Summary – Chart on Market Segmentation by Distribution Channel
Exhibits6: Executive Summary – Chart on Market Segmentation by Indication
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on Global retinal drugs market 2017 – 2021 ($ million)
Exhibits19: Historic Market Size – Ditribution channel Segment 2017 – 2021 ($ million)
Exhibits20: Historic Market Size – Indication Segment 2017 – 2021 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Distribution Channel – Market share 2022-2027 (%)
Exhibits31: Data Table on Distribution Channel – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Distribution Channel
Exhibits33: Data Table on Comparison by Distribution Channel
Exhibits34: Chart on Hospital pharmacy – Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Hospital pharmacy – Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Hospital pharmacy – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Hospital pharmacy – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Retail pharmacy – Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Retail pharmacy – Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Retail pharmacy – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Retail pharmacy – Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Online pharmacy – Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Online pharmacy – Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Online pharmacy – Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Online pharmacy – Year-over-year growth 2022-2027 (%)
Exhibits46: Market opportunity by Distribution Channel ($ million)
Exhibits47: Chart on Indication – Market share 2022-2027 (%)
Exhibits48: Data Table on Indication – Market share 2022-2027 (%)
Exhibits49: Chart on Comparison by Indication
Exhibits50: Data Table on Comparison by Indication
Exhibits51: Chart on Macular degeneration – Market size and forecast 2022-2027 ($ million)
Exhibits52: Data Table on Macular degeneration – Market size and forecast 2022-2027 ($ million)
Exhibits53: Chart on Macular degeneration – Year-over-year growth 2022-2027 (%)
Exhibits54: Data Table on Macular degeneration – Year-over-year growth 2022-2027 (%)
Exhibits55: Chart on Diabetic eye disease – Market size and forecast 2022-2027 ($ million)
Exhibits56: Data Table on Diabetic eye disease – Market size and forecast 2022-2027 ($ million)
Exhibits57: Chart on Diabetic eye disease – Year-over-year growth 2022-2027 (%)
Exhibits58: Data Table on Diabetic eye disease – Year-over-year growth 2022-2027 (%)
Exhibits59: Chart on Others – Market size and forecast 2022-2027 ($ million)
Exhibits60: Data Table on Others – Market size and forecast 2022-2027 ($ million)
Exhibits61: Chart on Others – Year-over-year growth 2022-2027 (%)
Exhibits62: Data Table on Others – Year-over-year growth 2022-2027 (%)
Exhibits63: Market opportunity by Indication ($ million)
Exhibits64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits65: Chart on Market share by geography 2022-2027 (%)
Exhibits66: Data Table on Market share by geography 2022-2027 (%)
Exhibits67: Chart on Geographic comparison
Exhibits68: Data Table on Geographic comparison
Exhibits69: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits70: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits71: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits72: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits73: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits74: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits75: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits76: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits77: Chart on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits78: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits79: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits82: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits83: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits86: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits87: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on China – Market size and forecast 2022-2027 ($ million)
Exhibits90: Data Table on China – Market size and forecast 2022-2027 ($ million)
Exhibits91: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits94: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits95: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits97: Chart on Spain – Market size and forecast 2022-2027 ($ million)
Exhibits98: Data Table on Spain – Market size and forecast 2022-2027 ($ million)
Exhibits99: Chart on Spain – Year-over-year growth 2022-2027 (%)
Exhibits100: Data Table on Spain – Year-over-year growth 2022-2027 (%)
Exhibits101: Chart on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits102: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits103: Chart on Canada – Year-over-year growth 2022-2027 (%)
Exhibits104: Data Table on Canada – Year-over-year growth 2022-2027 (%)
Exhibits105: Market opportunity by geography ($ million)
Exhibits106: Impact of drivers and challenges in 2022 and 2027
Exhibits107: Overview on Criticality of inputs and Factors of differentiation
Exhibits108: Overview on factors of disruption
Exhibits109: Impact of key risks on business
Exhibits110: Vendors covered
Exhibits111: Matrix on vendor position and classification
Exhibits112: AbbVie Inc. – Overview
Exhibits113: AbbVie Inc. – Product / Service
Exhibits114: AbbVie Inc. – Key news
Exhibits115: AbbVie Inc. – Key offerings
Exhibits116: Alcon Inc. – Overview
Exhibits117: Alcon Inc. – Business segments
Exhibits118: Alcon Inc. – Key offerings
Exhibits119: Alcon Inc. – Segment focus
Exhibits120: Alimera Sciences Inc. – Overview
Exhibits121: Alimera Sciences Inc. – Product / Service
Exhibits122: Alimera Sciences Inc. – Key offerings
Exhibits123: Bausch Health Co Inc. – Overview
Exhibits124: Bausch Health Co Inc. – Business segments
Exhibits125: Bausch Health Co Inc. – Key news
Exhibits126: Bausch Health Co Inc. – Key offerings
Exhibits127: Bausch Health Co Inc. – Segment focus
Exhibits128: Bayer AG – Overview
Exhibits129: Bayer AG – Business segments
Exhibits130: Bayer AG – Key news
Exhibits131: Bayer AG – Key offerings
Exhibits132: Bayer AG – Segment focus
Exhibits133: Bristol Myers Squibb Co. – Overview
Exhibits134: Bristol Myers Squibb Co. – Product / Service
Exhibits135: Bristol Myers Squibb Co. – Key news
Exhibits136: Bristol Myers Squibb Co. – Key offerings
Exhibits137: F. Hoffmann La Roche Ltd. – Overview
Exhibits138: F. Hoffmann La Roche Ltd. – Business segments
Exhibits139: F. Hoffmann La Roche Ltd. – Key news
Exhibits140: F. Hoffmann La Roche Ltd. – Key offerings
Exhibits141: F. Hoffmann La Roche Ltd. – Segment focus
Exhibits142: Johnson and Johnson Services Inc. – Overview
Exhibits143: Johnson and Johnson Services Inc. – Business segments
Exhibits144: Johnson and Johnson Services Inc. – Key news
Exhibits145: Johnson and Johnson Services Inc. – Key offerings
Exhibits146: Johnson and Johnson Services Inc. – Segment focus
Exhibits147: MeiraGTx Holdings Plc – Overview
Exhibits148: MeiraGTx Holdings Plc – Product / Service
Exhibits149: MeiraGTx Holdings Plc – Key offerings
Exhibits150: Novartis AG – Overview
Exhibits151: Novartis AG – Business segments
Exhibits152: Novartis AG – Key offerings
Exhibits153: Novartis AG – Segment focus
Exhibits154: Ocular Therapeutix Inc. – Overview
Exhibits155: Ocular Therapeutix Inc. – Product / Service
Exhibits156: Ocular Therapeutix Inc. – Key offerings
Exhibits157: Oxurion NV – Overview
Exhibits158: Oxurion NV – Product / Service
Exhibits159: Oxurion NV – Key offerings
Exhibits160: Pfizer Inc. – Overview
Exhibits161: Pfizer Inc. – Product / Service
Exhibits162: Pfizer Inc. – Key news
Exhibits163: Pfizer Inc. – Key offerings
Exhibits164: Regeneron Pharmaceuticals Inc. – Overview
Exhibits165: Regeneron Pharmaceuticals Inc. – Product / Service
Exhibits166: Regeneron Pharmaceuticals Inc. – Key offerings
Exhibits167: Sanofi SA – Overview
Exhibits168: Sanofi SA – Business segments
Exhibits169: Sanofi SA – Key news
Exhibits170: Sanofi SA – Key offerings
Exhibits171: Sanofi SA – Segment focus
Exhibits172: Inclusions checklist
Exhibits173: Exclusions checklist
Exhibits174: Currency conversion rates for US$
Exhibits175: Research methodology
Exhibits176: Validation techniques employed for market sizing
Exhibits177: Information sources
Exhibits178: List of abbreviations



★調査レポート[網膜治療薬のグローバル市場2023-2027:病院薬局、小売薬局、オンライン薬局] (コード:IRTNTR70326-23)販売に関する免責事項を必ずご確認ください。
★調査レポート[網膜治療薬のグローバル市場2023-2027:病院薬局、小売薬局、オンライン薬局]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆